Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ, USA.
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Expert Opin Drug Deliv. 2021 Feb;18(2):205-227. doi: 10.1080/17425247.2021.1828339. Epub 2020 Oct 8.
INTRODUCTION: Nanocarrier-based delivery systems offer multiple benefits to overcome limitations of the traditional drug dosage forms, such as protection of the drug, enhanced bioavailability, targeted delivery to disease site, etc. Nanocarriers have exhibited tremendous successes in targeted delivery of therapeutics to the desired tissues and cells with improved bioavailability, high drug loading capacity, enhanced intracellular delivery, and better therapeutic effect. A specific design of stimuli-responsive nanocarriers allows for changing their structural and physicochemical properties in response to exogenous and endogenous stimuli. These nanocarriers show a promise in site specific controlled release of therapeutics under certain physiological conditions or external stimuli. AREAS COVERED: This review highlights recent progresses on the multifunctional and stimuli-sensitive nanocarriers for targeted therapeutic drug delivery applications. EXPERT OPINION: The progress from single functional to multifunctional nanocarriers has shown tremendous potential for targeted delivery of therapeutics. On our opinion, the future of targeted delivery of drugs, nucleic acids, and other substances belongs to the site-targeted multifunctional and stimuli-based nanoparticles with controlled release. Targeting of nanocarriers to the disease site enhance the efficacy of the treatment by delivering more therapeutics specifically to the affected cells and substantially limiting adverse side effects upon healthy organs, tissues, and cells.
简介:基于纳米载体的递药系统为克服传统药物剂型的局限性提供了多种优势,例如保护药物、提高生物利用度、靶向递送至疾病部位等。纳米载体在将治疗药物靶向递送至所需组织和细胞方面取得了巨大成功,提高了生物利用度、高载药量、增强细胞内递药能力和更好的治疗效果。刺激响应型纳米载体的特定设计允许其响应外源性和内源性刺激来改变其结构和物理化学性质。这些纳米载体有望在特定生理条件或外部刺激下实现治疗药物的位点特异性控制释放。
涵盖领域:本文重点介绍了用于靶向治疗药物递送应用的多功能和刺激敏感型纳米载体的最新进展。
专家意见:从单一功能到多功能纳米载体的进展为治疗药物的靶向递送展示了巨大的潜力。我们认为,药物、核酸和其他物质的靶向递送的未来属于具有控制释放的基于位点靶向的多功能和刺激响应型纳米颗粒。纳米载体对疾病部位的靶向作用通过将更多的治疗药物特异性递送至受影响的细胞,同时大大限制对健康器官、组织和细胞的不良副作用,从而增强治疗效果。
Expert Opin Drug Deliv. 2021-2
Pharmaceutics. 2022-10-15
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021-1
J Control Release. 2008-3-20
Adv Drug Deliv Rev. 2017-4-7
Expert Opin Drug Deliv. 2022-11
Chem Pharm Bull (Tokyo). 2017
Mater Today Bio. 2025-7-4
Nanomaterials (Basel). 2025-7-4
ACS Biomater Sci Eng. 2017-7-10
Front Bioeng Biotechnol. 2020-4-2
Front Bioeng Biotechnol. 2020-3-10
Pharmaceutics. 2019-11-17
Adv Drug Deliv Rev. 2019-8-7